REVIEW ON AN ARB HAVING HIGHER ASSOCIATION LOWER DISSOCIATION INDEX FOR A RECEPTOR: A NEW TREND IN ACHIEVEMENT OF HYPERTENSION GOAL

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 8

Abstract

OLMESARTAN medoxomil (angiotensin II receptor blockers (ARBs) having blood pressure lowering efficacy similar to other antihypertensive agents. Recent large-scale, randomized, controlled clinical trials have demonstrated that ARBs offer cardiovascular and renal protective benefits independent of their effects on systemic blood pressure (BP), which make them valuable as first-line antihypertensive agents, especially in high-risk patients. However, as is the case with other antihypertensive classes, monotherapy with the first-available ARBs may not provide sufficient BP reduction to achieve currently recommended BP goals in many patients. The angiotensin II receptor blockers (ARBs) are well tolerated and demonstrate significant BP reduction. Olmesartan medoxomil, an ARB, has been well studied and achieves significant BP lowering and goal achievement with good tolerability. Olmesartan medoxomil is the latest angiotensin II receptor include once-daily dosing, an absence of significant adverse reactions, a well-tolerated side-effect profile, and a cost-effective average wholesale price. Olmesartan medoxomil is currently being used as an alternative therapeutic antihypertensive agent for patients intolerant of angiotensin-converting enzyme inhibitors(ACEIs).

Authors and Affiliations

Bharat Bhushan*| Sunder Deep Pharmacy College, Ghaziabad, UP, India, Satish Kumar Sharma| Sunder Deep Pharmacy College, Ghaziabad, UP, India, Lalit Singh| Sunder Deep Pharmacy College, Ghaziabad, UP, India, Komal Gupta| Indira College of Pharmacy, Pune, Maharashtra, India

Keywords

Related Articles

One pot conventional synthesis and biological activity of some novel double schiff bases

In this work, we report the synthesis and biological activity of some new double Schiff bases derived from ethylene diamine with 2-acetylnaphthalene and 2-acetylpyridine and were characterised by using UV-Visible, FTIR,...

Effect of Momordica charantia L. leaves extract on biophysical and biochemical parameters of wound in experimentally induced diabetes in rats

Momordica charantia Linn. leave extrat in the form of an ointment (20% w/w dried powder in simple ointment base) was evaluated for wound-healing potential in an excision wound model whereas the the leave extract given or...

An open label observational study for Drug adherence in Type 2 Diabetes Mellitus patients

Diabetes mellitus is a heterogeneous group of disorders characterized by abnormalities in carbohydrate, protein, and lipid metabolism. The central disturbance in diabetes mellitus is an abnormality in insulin production...

FORMULATION DEVELOPMENT AND EVALUATION OF SUSTAINED RELEASE OXCARBAZEPINE TABLET

The Sustained release drug delivery systems that are designed to achieve or extend therapeutic effect by continuously releasing medication over an extended period of time after administration of a single dose, to individ...

To Study and Evaluate the Various Aspects in Manufacturing Amorphous Spray Dried Dispersion.

Spray-dried dispersions have become an significant formulation technology for the pharmaceutical product development of poorly water-soluble compounds. Even though this technology is now widely used in the industry, espe...

Download PDF file
  • EP ID EP1443
  • DOI -
  • Views 443
  • Downloads 48

How To Cite

Bharat Bhushan*, Satish Kumar Sharma, Lalit Singh, Komal Gupta (2013). REVIEW ON AN ARB HAVING HIGHER ASSOCIATION LOWER DISSOCIATION INDEX FOR A RECEPTOR: A NEW TREND IN ACHIEVEMENT OF HYPERTENSION GOAL. Journal of Drug Discovery and Therapeutics, 1(8), 23-27. https://europub.co.uk/articles/-A-1443